IIQ
INOVIQ LTD
$0.1500
▼ -3.23%
Market cap
$21M
Turnover
$18,813
Last price
$0.1500
Day change
-3.23%
Announcements
9
Range, past year
Open 0.385 · Low 0.150 · Now 0.150 · High 0.690
Open IIQ in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
IIQ momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
27/100
Wyckoff phase
Downtrend4d
Trend stage
Breakdown
1 Day
-3.2%
1 Week
-9.1%
1 Month
-11.8%
1 Year
-61.0%
RSI
34
Avg daily range
5.4%
INOVIQ LTD scores 27 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 4 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Trend R² 0.81 — highly linear uptrend
Points to watch
- 60d drawdown -30.2%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsIIQ announcements
Recent price-sensitive releases.
- 2026-09-30 EXO-OC Technical Review and Commercialisation Pathway Progress Report
- 2026-08-27 Appendix 4E and Preliminary Financial Report Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-14 EXO-OC Study Outcome Investor Webinar Presentation
- 2026-07-13 Quarterly Activities Report and Appendix 4C - June 2026
- 2026-07-01 EXO-OC algorithm and clinical study update
- 2026-06-29 Trading Halt
- 2026-06-25 Positive CAR-exosome data in ovarian cancer
More Health Care stocks
Most traded in the same sector.